1 Min Read
Halma has agreed to acquire French diagnostics company Dreampath in a deal that will expand its pathology portfolio and strengthen technologies supporting tissue sample management. The acquisition includes an initial cash payment of €154m, with additional performance-related payments of up to €121m linked to future milestones. Dreampath develops automated systems that enable pathology laboratories to […] The post Halma acquires pathology automation specialist Dreampath appeared first on Pharmafile.
Work & Theory on July 12, 2026
Uncategorized